TalkMed CEO suspended for eight months
Add BT as a preferred sourcePROMINENT cancer specialist Ang Peng Tiam, who is the chief executive officer and main revenue contributor of Catalist-listed TalkMed Group, has been given an eight-month suspension by the Singapore Medical Council after a failed appeal against a misconduct conviction.
Dr Ang contributes over half of the revenue of the firm. He had originally appealed against his S$25,000 fine by the Singapore Medical Council.
TalkMed requested for a trading halt on Wednesday morning. Its shares last traded at S$0.745.
Share with us your feedback on BT's products and services
TRENDING NOW
When every phone becomes a satellite phone, what happens to Asia’s telcos?
Bessent’s bond manoeuvres giving global debasement trade new life
Laos-China Railway picks up steam, but S-E Asian country struggles to capture gains
Too little, too late? Manila’s billion-dollar bid to ignite its sputtering EV industry
